Safety profile and clinical course of patients with insomnia administered suvorexant by initial treatment status in a post-marketing survey

Hideki Sano(MSD K.K. (Japan)), Mitsuyoshi Hara(MSD K.K. (Japan)), Makoto Miyazaki(Chiba Cancer Center), Yuko Asai(MSD K.K. (Japan)), Mika Iwakura(MSD K.K. (Japan)), Yoshikazu Maeda(Fukui Prefectural Hospital)
Expert Opinion on Drug Safety
September 3, 2019
Cited by 9


Related Papers